UBS maintains Cerebras Systems at Buy, lowers price target to $155 from $250

What happened

UBS maintained its Buy rating on Cerebras Systems and lowered its price target to $155 from $250, a 38.0% decrease. The revised target implies 58.6% upside from the November 12 closing price of $97.75.

Confirmed

Global impact / market context

The lower target signals that UBS now sees less potential value in Cerebras than before, despite keeping its Buy rating. If investors rely on analyst targets when deciding whether to buy or sell, the cut could influence demand for the stock, though it does not change company revenue or costs directly.

Analyst inference

Recent analyst targets in the article range from $175 to $250 across five notes, while UBS’s new $155 target is below that range. The range shows differing views, but these targets are estimates rather than guarantees of future share prices.

Confirmed

What to watch

1. Check whether UBS explains the target reduction in later coverage; the supplied article gives no reason, so changes to its assumptions cannot yet be identified. Analyst inference
2. Compare future analyst targets with UBS’s $155 figure and the reported $175–$250 range to see whether other analysts revise their expectations. Analyst inference
3. Track Cerebras’ reported business results and outlook for evidence that could support or weaken the lower target; this article provides no operating details. Analyst inference

Evidence

• Original source link unavailable